Esperion Therapeutics
ESPR
#7072
Rank
A$0.51 B
Marketcap
$2.62
Share price
0.57%
Change (1 day)
37.81%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$1.04 B

According to Esperion Therapeutics's latest financial reports the company's total liabilities are A$1.04 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$0.96 B15.44%
2022-12-31A$0.84 B5.59%
2021-12-31A$0.79 B36.43%
2020-12-31A$0.58 B110.78%
2019-12-31A$0.27 B203.09%
2018-12-31A$91.28 M115.03%
2017-12-31A$42.45 M84.23%
2016-12-31A$23.04 M101.92%
2015-12-31A$11.41 M-3.74%
2014-12-31A$11.85 M151.6%
2013-12-31A$4.71 M-80.22%
2012-12-31A$23.82 M196.6%
2011-12-31A$8.03 M
2002-12-31A$22.47 M-3.13%
2001-12-31A$23.2 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$1.77 B 70.27%๐Ÿ‡บ๐Ÿ‡ธ USA
A$2.67 B 155.67%๐Ÿ‡บ๐Ÿ‡ธ USA
A$192.31 B 18,307.87%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.82 B 1,031.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.92 B-11.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.20 B-80.85%๐Ÿ‡บ๐Ÿ‡ธ USA